Pregnolia raises €4.4M Series A round
25 June 2020· Schlieren, Switzerland· health, women_health, medical_device, diagnostics, software_hardware, b2b
The funding will enable Pregnolia to take a significant step towards establishing its system as the de facto standard for preterm birth diagnostics. This includes marketing the Pregnolia System as a diagnostic device, collaborating with early adopters, obtaining a CE mark, creating a distribution network in Europe, and establishing reimbursements.
Investors
LeadInvestiere
Also participating
SwissHealth Ventures
About Pregnolia
Stage
Series A
Headquarters
Schlieren, Switzerland
Founded
2016
Team Size
6–20
Sectors
healthwomen_healthmedical_devicediagnosticssoftware_hardwareb2b